Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2326 AL 2340

Effectiveness of Safinamide over Mood in Parkinson's Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

Labandeira CM, Alonso Losada MG, Yáñez Baña R, Cimas Hernando MI, Cabo López I, Paz González JM, Gonzalez Palmás MJ, Martínez Miró C, Santos García D.

Adv Ther. 2021 Oct;38(10):5398-5411. doi: 10.1007/s12325-021-01873-w. Epub 2021 Sep 15.

Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone

Jenner P, Rocha JF, Ferreira JJ, Rascol O, Soares-da-Silva P.

Expert Rev Neurother. 2021 Sep;21(9):1019-1033. doi: 10.1080/14737175.2021.1968298. Epub 2021 Sep 15.

Assessing the usability of wearable devices to measure gait and physical activity in chronic conditions: a systematic review

Keogh A, Argent R, Anderson A, Caulfield B, Johnston W.

J Neuroeng Rehabil. 2021 Sep 15;18(1):138. doi: 10.1186/s12984-021-00931-2.

Rapid Destructive Arthropathy of the Knee in Parkinson's Disease with Pisa Syndrome: A Case of Knee-Spine Syndrome

Takai H, Kitajima M, Takai S, Takahashi T, Katsura KI, Tokunaga M, Watanabe S.

Case Rep Orthop. 2021 Sep 3;2021:6622445. doi: 10.1155/2021/6622445. eCollection 2021.

Extracellular Vesicles in Health and Disease

Shetty AK, Upadhya R.

Aging Dis. 2021 Sep 1;12(6):1358-1362. doi: 10.14336/AD.2021.0827. eCollection 2021 Sep.

Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease

Upadhya R, Shetty AK.

Aging Dis. 2021 Sep 1;12(6):1438-1450. doi: 10.14336/AD.2021.0516. eCollection 2021 Sep.

Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's Disease

Leggio L, Paternò G, Vivarelli S, Falzone GG, Giachino C, Marchetti B, Iraci N.

Aging Dis. 2021 Sep 1;12(6):1494-1515. doi: 10.14336/AD.2021.0527. eCollection 2021 Sep.

Glucocerebrosidase dysfunction in neurodegenerative disease

Brooker SM, Krainc D.

Essays Biochem. 2021 Dec 22;65(7):873-883. doi: 10.1042/EBC20210018.

Retromer dependent changes in cellular homeostasis and Parkinson's disease

Yang Z, Li Z, Teasdale RD.

Essays Biochem. 2021 Dec 22;65(7):987-998. doi: 10.1042/EBC20210023.

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease

Meles SK, Oertel WH, Leenders KL.

Mol Med. 2021 Sep 16;27(1):111. doi: 10.1186/s10020-021-00327-x.

"Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism

Necpál J, Borsek M, Jeleňová B.

Neurol Sci. 2021 Dec;42(12):4927-4936. doi: 10.1007/s10072-021-05601-8. Epub 2021 Sep 17.

The role of neuroimaging in Parkinson's disease

Bidesi NSR, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM.

J Neurochem. 2021 Nov;159(4):660-689. doi: 10.1111/jnc.15516. Epub 2021 Oct 3.

An overview of recent analysis and detection of acetylcholine

Gu X, Wang X.

Anal Biochem. 2021 Nov 1;632:114381. doi: 10.1016/j.ab.2021.114381. Epub 2021 Sep 14.

Parkinson's disease outside the brain: targeting the autonomic nervous system

Sharabi Y, Vatine GD, Ashkenazi A.

Lancet Neurol. 2021 Oct;20(10):868-876. doi: 10.1016/S1474-4422(21)00219-2.

Alternative platelet activation pathways and their role in neurodegenerative diseases

Ferrer-Raventós P, Beyer K.

Neurobiol Dis. 2021 Nov;159:105512. doi: 10.1016/j.nbd.2021.105512. Epub 2021 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias